Compare SCTX & YICC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SCTX | YICC |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 330.1M | 351.2M |
| IPO Year | 2026 | 2026 |
| Metric | SCTX | YICC |
|---|---|---|
| Price | $27.59 | $9.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 187.6K | 84.3K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $17.31 | $9.86 |
| 52 Week High | $26.50 | $9.95 |
| Indicator | SCTX | YICC |
|---|---|---|
| Relative Strength Index (RSI) | 63.58 | 65.79 |
| Support Level | $19.09 | N/A |
| Resistance Level | N/A | $9.95 |
| Average True Range (ATR) | 2.75 | 0.01 |
| MACD | 0.21 | 0.01 |
| Stochastic Oscillator | 96.86 | 70.59 |
Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.
Yorkville International Capital Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.